Pharmacodynamic Tolerance
Pharmacodynamic Tolerance is a form of drug tolerance characterized by a diminished pharmacological response to a substance due to adaptive changes in target cells or receptor systems, despite maintained drug concentrations at the site of action.
139
Publications
5.5K
Citations
413
Authors
164
Institutions
Publications per year
2017–2026
2
Variants
Pharmacodynamic Drug Tolerance
139
1–5 of 139
413
4
h-index
3
h-index
3
h-index
3
h-index
2
h-index
1–5 of 413
164
University of Washington
Seattle, United States
5 h-index
12 publications
842 citations
National Institute of Mental Health
Bethesda, United States
5 h-index
11 publications
744 citations

University of Minnesota
Minneapolis, United States
4 h-index
11 publications
284 citations
United States Public Health Service
Washington D.C., United States
3 h-index
9 publications
679 citations
Emory University
Atlanta, United States
3 h-index
5 publications
253 citations

University of Mississippi Medical Center
Jackson, United States
3 h-index
10 publications
212 citations
Rutgers, The State University of New Jersey
New Brunswick, United States
3 h-index
5 publications
145 citations

Karolinska Institutet
Stockholm, Sweden
2 h-index
4 publications
149 citations
1–8 of 164
23 publications · 731 citations
16
h-index
EJP · 12 publications · 440 citations
11
h-index
10 publications · 331 citations
10
h-index
8 publications · 173 citations
8
h-index
7 publications · 438 citations
7
h-index
1–5